Brief: Sesen Bio Terminates Master Bioprocessing Services Deal With Fujifilm Diosynth Biotech U.S.A.

Carisma Therapeutics

21/07/2022 13:50

July 21 (Reuters) - Sesen Bio Inc  SESN.O :
    * SESEN BIO - ON JULY 17, TERMINATED MASTER BIOPROCESSING
SERVICES
AGREEMENT DATED OCT 4, 2018, BETWEEN CO, FUJIFILM DIOSYNTH
BIOTECHNOLOGIES U.S.A.
    * SESEN BIO - HAS REQUESTED THAT FUJIFILM CEASE ALL WORK
UNDER THE
AGREEMENT AND REFRAIN FROM INCURRING ANY ADDITIONAL COSTS OR
EXPENSES
    * SESEN BIO - AS A RESULT OF  TERMINATION, CO TO PAY
FUJIFILM FOR
CERTAIN NON-MANUFACTURING STAGE SERVICES & CGMP BATCHES OF DRUG
SUBSTANCE OF VICINEUM
    * SESEN BIO - TERMINATED AGREEMENT WITH FUJIFILM AS A RESULT
OF
CO'S PREVIOUSLY DISCLOSED RESTRUCTURING PLAN

Further company coverage:  SESN.O 

 ((Reuters.Briefs@thomsonreuters.com;))